Phacoemulsification Machines and Consumables

A Contract Award Notice
by NHS GREATER GLASGOW AND CLYDE

Source
OJEU
Type
Contract (Supply)
Duration
5 year (est.)
Value
___
Sector
HEALTH
Published
15 Jun 2022
Delivery
To 15 Jun 2027 (est.)
Deadline
n/a

Concepts

Location

Sites covered by the NHS Greater Glasgow and Clyde Health Board

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

The Procurement of Phacoemulsification machines, associated hand pieces, associated suction cassettes and a procedure pack as detailed in the specification. NHS Greater Glasgow and Clyde requires that the Phacoemulsification machines and associated hand pieces are provided free on loan with no up front cost for the duration of the contract period.

Total Quantity or Scope

NHS Greater Glasgow and Clyde requires that the Phacoemulsification machines and associated hand pieces are provided free on loan with no up front cost for the duration of the contract.

Award Detail

1 Unnamed (None)
  • Reference: ggc0605
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.

Award Criteria

Technical 50.0
Commercial 50.0

CPV Codes

  • 33122000 - Ophthalmology equipment
  • 33140000 - Medical consumables

Indicators

  • Award on basis of price and quality.

Other Information

The Tender will be evaluated based on the Most Economically Advantageous Tender (MEAT) Only the top 2 scoring contractors using MEAT will be taken to the clinical trial. Award Criteria Tender responses will be evaluated against the award criteria detailed below. First Stage – Selection Criteria (noted above) – All tenderers passing this stage will be taken to the next stage Second Stage – Mandatory Requirements – All tenderers passing this stage will be taken to the next stage Third Stage - Quality & Technical Response (27%) – Only the top two scoring tenderers will be taken to the next stage. Fourth Stage - Clinical evaluation (35%) – From the top two scoring tenderers, two companies will be taken to the final stage. The Short-listed candidates will be invited to have their Machines evaluated in a clinical environment. (Specific details regarding sites, duration of product trials etc will be advised, although it is currently proposed that 5 or 6 sites may be involved: Queen Elizabeth University Hospital, Gartnavel General Hospital, Stobhill Hospital, Victoria ACH, Royal Alexandra Hospital and Inverclyde Royal Hospital). The latter two may combine their trial. It is expected that the trials will last for 2 weeks, with Machines and consumables being offered free for the duration of the trial. Final Stage – Quality Score and Commercial Costs – This will identify the Most Economical Advantageous Tenderer. (SC Ref:696519)

Reference

Domains